P00517 (KAPCA_BOVIN) Bos taurus (Bovine)

cAMP-dependent protein kinase catalytic subunit alpha UniProtKBInterProSTRINGInteractive Modelling

351 aa; Sequence (Fasta)
Identical sequences: Bos indicus: A0A6P5C1U0; Bos indicus x Bos taurus: A0A4W2GDJ9

Available Structures

89 Experimental Structures

DescriptionOligo-stateLigandsStructureRange
Protein kinase A variant complex with completely ordered N-terminal helix Heteromer
P61926;
BU3;MG8;2-351
Assess
Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase A and Mu… Heteromer
P61925;
R68;2-351
Assess
The Catalytic Subunit of cAMP-dependent Protein Kinase in Complex with Rho-kinase Inhibitor H-1152P Heteromer
P63249;
H52;MG8;8-351
Assess
The Synthesis and Evaluation of Diazaspirocyclic Protein Kinase Inhibitors Heteromer
Q3SX13;
15I;GOL;MPD;8-351
Assess
Crystal structures of the kinase domain of PKA in complex with ATP-competitive inhibitors Heteromer
Q3SX13;
G98;8-351
Assess
Crystal structures of the kinase domain of PKA in complex with ATP-competitive inhibitors Heteromer
Q3SX13;
G96;8-351
Assess
Crystal Structure of Protein Kinase A in Complex with Azepane Derivative 1 Heteromer
P61926;
NA;I01;MG8;8-351
Assess
Structure of PKA-PKB chimera complexed with C-(4-(4-Chlorophenyl)-1-(7H-pyrrolo(2,3-d)pyrimidin-4-y… Heteromer
P61925;
CL;MRD;EDO;M03;9-351
Assess
The Synthesis and Evaluation of Diazaspirocyclic Protein Kinase Inhibitors Heteromer
Q3SX13;
SIJ;GOL;MOH;10-351
Assess
PKA-S6K1 Chimera with Staurosporine bound Heteromer
Q3SX13;
STU;GOL;MG8;11-351
Assess
Protein kinase A fivefold mutant model of Rho-kinase Heteromer
P63248;
11-351
Assess
The Catalytic Subunit of cAMP-dependent Protein Kinase (PKA) in Complex with Rho-kinase Inhibitor Y… Heteromer
P61925;
Y27;11-351
Assess
Crystal Structure of Protein Kinase A in Complex with Azepane Derivative 4 Heteromer
P61926;
I04;11-351
Assess
PKA five fold mutant model of Rho-kinase with H1152P Heteromer
P61926;
H52;11-351
Assess
PKA-S6K1 Chimera with compound 1 (NU1085) bound Heteromer
Q3SX13;
NU3;MPD;11-351
Assess
PKA fivefold mutant model of Rho-kinase with inhibitor Fasudil (HA1077) Heteromer
P61925;
M77;11-351
Assess
Protein kinase A fivefold mutant model of Rho-kinase with Y-27632 Heteromer
P63248;
Y27;11-351
Assess
Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase A and Mu… Heteromer
P61925;
R96;11-351
Assess
Crystal Structure of Protein Kinase A in Complex with Azepane Derivative 5 Heteromer
P61925;
I05;11-351
Assess
The Synthesis and Evaluation of Diazaspirocyclic Protein Kinase Inhibitors Heteromer
Q3SX13;
QNI;MOH;GOL;12-351
Assess
PKA threefold mutant model of Rho-kinase with inhibitor H-1152P Heteromer
P61926;
H52;12-351
Assess
Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase A and Mu… Heteromer
P61925;
R55;13-351
Assess
Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase A and Mu… Heteromer
P61925;
R69;BU3;14-351
Assess
PKA-S6K1 Chimera with compound 21a (CCT196539) bound Heteromer
Q3SX13;
Z21;MPD;14-351
Assess
PKA-S6K1 Chimera Apo Heteromer
Q3SX13;
14-351
Assess
Structure of PKA with a protein Kinase B-selective inhibitor. Heteromer
B99;14-351
Assess
Structure of PKA-PKB chimera complexed with 4-(4-Chlorobenzyl)-1-(7H- pyrrolo(2,3-d)pyrimidin-4-yl)… Heteromer
P61925;
CL;M05;14-351
Assess
PKA-S6K1 Chimera with compound 15e (CCT147581) bound Heteromer
Q3SX13;
ZO9;MOH;14-351
Assess
cAMP-dependent protein kinase PKA catalytic subunit with PKI-5-24 Heteromer
P61926;
LL1;14-351
Assess
PKA double mutant model of PKB Heteromer
P61925;
14-351
Assess
PKAB3 in complex with pyrrolidine inhibitor 34a Heteromer
P61925;
NVX;MOH;15-351
Assess
PKA-S6K1 Chimera with compound 21e (CCT239066) bound Heteromer
Q3SX13;
VUP;MOH;15-351
Assess
The Synthesis and Evaluation of Diazaspirocyclic Protein Kinase Inhibitors Heteromer
Q3SX13;
MPD;QWI;GOL;DMS;15-351
Assess
PKAB3 in complex with pyrrolidine inhibitor 47a Heteromer
P61925;
4L7;15-351
Assess
cAMP-dependent protein kinase PKA catalytic subunit with PKI-5-24 Heteromer
P61926;
OCT;15-351
Assess
Structure of PKA-PKB chimera complexed with (1S)-2-amino-1-(4- chlorophenyl)-1-(4-(1H-pyrazol-4-yl)… Heteromer
P61925;
RKD;15-351
Assess
Bovine PKA C-alpha in complex with 3-pyridylmethyl-5-methyl-1H-pyrazole-3-carboxylate Heteromer
P61925;
PZX;GOL;15-351
Assess
Structure of PKA-PKB chimera complexed with C-Phenyl-C-(4-(9H-purin-6- yl)-phenyl)-methylamine Heteromer
P61925;
GVJ;15-351
Assess
Structure of cAMP-dependent protein kinase complexed with Isoquinoline-5-sulfonic acid (2-(2-(4-chl… Heteromer
P61925;
I5S;15-351
Assess
Crystal structure of Protein Kinase A in complex with the PKI peptide and Aminobenzothiazole based … Heteromer
Q3SX13;
9D4;15-351
Assess
Structure of PKA-PKB chimera complexed with (1-(9H-Purin-6-yl) piperidin-4-yl)amine Heteromer
P61925;
M02;15-351
Assess
Structure of PKA-PKB chimera complexed with C-(4-(4-Chlorophenyl)-1-(7H-pyrrolo(2,3-d)pyrimidin-4-y… Heteromer
P61925;
CL;M04;15-351
Assess
Structure of PKA complexed with 4-(4-Chlorobenzyl)-1-(7H-pyrrolo(2,3- d)pyrimidin-4-yl)piperidin-4-… Heteromer
P61925;
M05;15-351
Assess
Structure of PKA-PKB chimera complexed with 6-(4-(4-(4-Chloro-phenyl) -piperidin-4-yl)-phenyl)-9H-p… Heteromer
P61925;
GVK;15-351
Assess
Structure of PKA-PKB chimera complexed with 2-(4-(5-methyl-1H-pyrazol- 4-yl)-phenyl)-ethylamine Heteromer
P61925;
L15;15-351
Assess
Structure of cAMP-dependent protein kinase complexed with (4R,2S)-5'-(4-(4-Chlorobenzyloxy)pyrrolid… Heteromer
P61925;
CQP;15-351
Assess
Structure of PKA-PKB chimera complexed with 7-azaindole Heteromer
P61925;
GVH;15-351
Assess
Structure of PKA-PKB chimera complexed with 2-(4-chloro-phenyl)-2- phenyl-ethylamine Heteromer
P61925;
GVQ;15-351
Assess
Structure of cAMP-dependent protein kinase complexed with A-443654 Heteromer
P61925;
L20;15-351
Assess
Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase A and Mu… Heteromer
P61925;
R68;BU3;15-351
Assess
Structure of PKA-PKB chimera complexed with (1-(9H-Purin-6-yl) piperidin-4-yl)methanamine Heteromer
P61925;
M01;15-351
Assess
Structure of PKA-PKB chimera complexed with 4-(4-chloro-phenyl)-4-(4- (1H-pyrazol-4-yl)-phenyl)-pip… Heteromer
P61925;
GVP;15-351
Assess
PKA triple mutant model of PKB Heteromer
P61925;
MG8;15-351
Assess
CAMP-DEPENDENT PROTEIN KINASE PKA CATALYTIC SUBUNIT WITH PKI-5-24 Heteromer
P61926;
EMU;15-351
Assess
Structure of PKA-PKB chimera complexed with 5-methyl-4-phenyl-1H- pyrazole Heteromer
P61925;
GVG;15-351
Assess
The Catalytic Subunit of cAMP-dependent Protein Kinase in Complex with Rho-kinase Inhibitor Fasudil… Heteromer
P61926;
M77;15-351
Assess
Structure of PKA-PKB chimera complexed with (S)-2-(4-chloro-phenyl)- 2-(4-1H-pyrazol-4-yl)-phenyl)-… Heteromer
P61925;
GVO;15-351
Assess
PKA three fold mutant model of Rho-kinase with Y-27632 Heteromer
Q3SX13;
Y27;15-351
Assess
Crystal Structure of Protein Kinase A in Complex with Azepane Derivative 8 Heteromer
P63249;
I08;15-351
Assess
Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase A and Mu… Heteromer
P61925;
R69;15-351
Assess
Bovine PKA C-alpha in complex with 2-[[5-(4-pyridyl)-1H-1,2,4-triazol-3-yl]sulfanyl]-1-(2-thiopheny… Heteromer
P61925;
PTV;15-351
Assess
PKA double mutant model of PKB in complex with MgATP Heteromer
Q71U53;
MG;ATP;15-351
Assess
Protein Kinase A bound to (S)-2-(1H-Indol-3-yl)-1-[5-((E)-2-pyridin-4-yl-vinyl)-pyridin-3-yloxymeth… Heteromer
Q71U53;
4EA;16-351
Assess
Structure of PKA-PKB chimera complexed with methyl-(4-(9H-purin-6-yl)- benzyl)-amine Heteromer
P61925;
GVI;16-351
Assess
PKA complexed with (S)-2-(1H-Indol-3-yl)-1-(5-isoquinolin-6-yl-pyridin-3-yloxymethyl-etylamine Heteromer
P61925;
2EA;16-351
Assess
CRYSTAL STRUCTURE OF PKA IN COMPLEX WITH inhibitor. Heteromer
Q3SX13;
0RW;16-351
Assess
Structure of PKA-PKB chimera complexed with A-443654 Heteromer
P61925;
L20;16-351
Assess
PKA structures of AKT, indazole-pyridine inhibitors Heteromer
Q3SX13;
SS3;16-351
Assess
Crystal structure of Protein Kinase A in complex with Pyridine-Pyrazolopyridine based inhibitors Heteromer
4PY;16-351
Assess
Structure of PKA-PKB chimera complexed with (R)-2-(4-chloro-phenyl)- 2-(4-1H-pyrazol-4-yl)-phenyl)-… Heteromer
P61925;
GVN;16-351
Assess
Structure of PKA-PKB chimera complexed with ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY) … Heteromer
P61925;
I5S;16-351
Assess
Crystal structure of Protein Kinase A in complex with Pyridine-Pyrazolopyridine Based Inhibitors Heteromer
2PY;16-351
Assess
STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT IN COMPLEX WITH H7 PROTEIN KINA… Heteromer
P61925;
IQP;16-351
Assess
PKA structures of indazole-pyridine series of AKT inhibitors Heteromer
Q3SX13;
SS4;16-351
Assess
Structure of CAMP-dependent protein kinase, alpha-catalytic subunit in complex with H8 protein kina… Heteromer
P63249;
IQS;16-351
Assess
cAMP-dependent protein kinase PKA catalytic subunit with PKI-5-24 Heteromer
P61926;
LL2;16-351
Assess
CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT IN COMPLEX WITH STAUROSPORINE Heteromer
P61926;
STU;16-351
Assess
STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT IN COMPLEX WITH H89 PROTEIN KIN… Heteromer
P63249;
IQB;16-351
Assess
PKA structures of indazole-pyridine series of AKT inhibitors Heteromer
Q3SX13;
L20;16-351
Assess
PKA structures of indazole-pyridine series of AKT inhibitors Heteromer
Q3SX13;
SS5;16-351
Assess
Protein Kinase A bound to (R)-1-(1H-Indol-3-ylmethyl)-2-(2-pyridin-4-yl-[1,7]naphtyridin-5-yloxy)-e… Heteromer
P61926;
6EA;16-351
Assess
Crystal structure of Protein Kinase A in complex with the PKI peptide and a pyridinylbenzamide base… Heteromer
P61925;
J0P;18-351
Assess
Crystal structure of Protein Kinase A in complex with the PKI peptide and Aminobenzothiazole based … Heteromer
Q3SX13;
9CY;19-351
Assess
Crystal structure of Protein Kinase A in complex with the PKI peptide and an amino-pyridinylbenzami… Heteromer
P61925;
J0G;19-351
Assess
Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase A and Mu… Heteromer
P61925;
R94;19-351
Assess
Crystal structure of Protein Kinase A in complex with the PKI peptide and Aminobenzothiazole based … Heteromer
Q3SX13;
9D1;19-351
Assess
Complex of PKA with the bisubstrate protein kinase inhibitor lead compound Arc-1034monomerARX;11-351
Assess
Complex of PKA with the bisubstrate protein kinase inhibitor ARC-1012monomer15-351
Assess
DUAL BINDING MODE OF BISINDOLYLMALEIMIDE 2 TO PROTEIN KINASE A (PKA)monomerBI4;16-351
Assess

Alignments